Corticotropin-releasing factor receptor subtype 2 in human colonic mucosa: Down-regulation in ulcerative colitis

World Journal of Gastroenterology

Volumn 19, Issue 9, 2013, Pages 1416-1423

  Chatzaki, Ekaterini ^a,b   Anton, Peter A ^c,d   Million, Mulugeta ^d   Lambropoulou, Maria ^b   Constantinidis, Theodoros ^b   Kolios, George ^b   Taché, Yvette ^c   Grigoriadis, Dimitri E ^a  

^a NEUROCRINE BIOSCIENCES INC   (United States)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Colonic mucosa; Corticotropin releasing factor; Corticotropin releasing factor receptor; Human immunodeficiency virus; Ulcerative colitis; Urocortin

Indexed keywords

BETA ACTIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; COLON BIOPSY; COLON MUCOSA; COLORECTAL CARCINOMA; CONTROLLED STUDY; DESCENDING COLON; FEMALE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOREACTIVITY; MALE; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGMOID; ULCERATIVE COLITIS;

EID: 84875089139     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i9.1416     Document Type: Article

References (55)

1. Langhorst J, Cobelens PM, Kavelaars A, Heijnen CJ, Benson S, Rifaie N, Dobos GJ, Schedlowski M, Elsenbruch S. Stress-related peripheral neuroendocrine-immune interactions in women with ulcerative colitis. Psychoneuroendocrinology 2007; 32: 1086-1096. [PMID: 17933470 DOI: 10.1016/ j.psyneuen.2007.09.003]
2. Mawdsley JE, Macey MG, Feakins RM, Langmead L, Rampton DS. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Gastroenterology 2006; 131: 410-419. [PMID: 16890594 DOI: 10.1053/j.gastro.2006.05.017]
3. Mawdsley JE, Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut 2005; 54: 1481-1491. [PMID: 16162953 DOI: 10.1136/ gut.2005.064261]
4. Mawdsley JE, Rampton DS. The role of psychological stress in inflammatory bowel disease. Neuroimmunomodulation 2006; 13: 327-336. [PMID: 17709955 DOI: 10.1159/000104861]
5. Isgar B, Harman M, Kaye MD, Whorwell PJ. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut 1983; 24: 190-192. [PMID: 6826101 DOI: 10.1136/gut.24.3.190]
6. Gareau MG, Silva MA, Perdue MH. Pathophysiological mechanisms of stress-induced intestinal damage. Curr Mol Med 2008; 8: 274-281. [PMID: 18537635 DOI: 10.2174/1566524 08784533760]
7. Langdon DE., R Levenstein, et al.--Ulcerative colitis in remission and stress. Am J Gastroenterol 2000; 95: 3653. [PMID: 11151915]
8. Levenstein S, Prantera C, Varvo V, Scribano ML, Andreoli A, Luzi C, Arcà M, Berto E, Milite G, Marcheggiano A. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol 2000; 95: 1213-1220. [PMID: 10811330 DOI: 10.1111/ j.1572-0241.2000.02012.x]
9. Porcelli P, Zaka S, Centonze S, Sisto G. Psychological distress and levels of disease activity in inflammatory bowel disease. Ital J Gastroenterol 1994; 26: 111-115. [PMID: 8061336]
10. Fekete EM, Zorrilla EP. Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs. Front Neuroendocrinol 2007; 28: 1-27. [PMID: 17083971 DOI: 10.1016/j.yfrne.2006.09.002]
11. Kozicz T. On the role of urocortin 1 in the non-preganglionic Edinger-Westphal nucleus in stress adaptation. Gen Comp Endocrinol 2007; 153: 235-240. [PMID: 17517410 DOI: 10.1016/ j.ygcen.2007.04.005]
12. Martinez V, Wang L, Million M, Rivier J, Taché Y. Urocortins and the regulation of gastrointestinal motor function and visceral pain. Peptides 2004; 25: 1733-1744. [PMID: 15476940 DOI: 10.1016/j.peptides.2004.05.025]
13. Perrin MH, Vale WW. Corticotropin releasing factor receptors and their ligand family. Ann N Y Acad Sci 1999; 885: 312-328. [PMID: 10816663 DOI: 10.1111/j.1749-6632.1999. tb08687.x]
14. Hauger RL, Grigoriadis DE, Dallman MF, Plotsky PM, Vale WW, Dautzenberg FM. International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands. Pharmacol Rev 2003; 55: 21-26. [PMID: 12615952 DOI: 10.1124/pr.55.1.3]
15. Chen R, Lewis KA, Perrin MH, Vale WW. Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 1993; 90: 8967-8971. [PMID: 7692441 DOI: 10.1073/pnas.90.19.8967]
16. Perrin MH, Donaldson CJ, Chen R, Lewis KA, Vale WW. Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology 1993; 133: 3058-3061. [PMID: 8243338 DOI: 10.1210/en.133.6.3058]
17. Hiroi N, Wong ML, Licinio J, Park C, Young M, Gold PW, Chrousos GP, Bornstein SR. Expression of corticotropin releasing hormone receptors type I and type II mRNA in suicide victims and controls. Mol Psychiatry 2001; 6: 540-546. [PMID: 11526468 DOI: 10.1038/sj.mp.4000908]
18. Lovenberg TW, Liaw CW, Grigoriadis DE, Clevenger W, Chalmers DT, De Souza EB, Oltersdorf T. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 1995; 92: 836-840. [PMID: 0007846062 DOI: 10.1073/ pnas.92.3.836]
19. 2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 1995; 136: 4139-4142. [PMID: 0007544278 DOI: 10.1210/en.136.9.4139]
20. 2gamma receptor. Mol Endocrinol 1998; 12: 1077-1085. [PMID: 0009717834 DOI: 10.1210/me.12.8.1077]
21. Kimura Y, Takahashi K, Totsune K, Muramatsu Y, Kaneko C, Darnel AD, Suzuki T, Ebina M, Nukiwa T, Sasano H. Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart. J Clin Endocrinol Metab 2002; 87: 340-346. [PMID: 11788672 DOI: 10.1210/jc.87.1.340]
22. Wu SV, Yuan PQ, Wang L, Peng YL, Chen CY, Taché Y. Identification and characterization of multiple corticotropinreleasing factor type 2 receptor isoforms in the rat esophagus. Endocrinology 2007; 148: 1675-1687. [PMID: 17218420 DOI: 10.1210/en.2006-0565]
23. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 1995; 378: 287-292. [PMID: 0007477349 DOI: 10.1038/378287a0]
24. Taché Y, Martinez V, Million M, Wang L. Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: role of brain corticotropin-releasing factor receptors. Am J Physiol Gastrointest Liver Physiol 2001; 280: G173-G177. [PMID: 11208537]
25. Larauche M, Kiank C, Tache Y. Corticotropin releasing factor signaling in colon and ileum: regulation by stress and pathophysiological implications. J Physiol Pharmacol 2009; 60 Suppl 7: 33-46. [PMID: 20388944]
26. Taché Y, Bonaz B. Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. J Clin Invest 2007; 117: 33-40. [PMID: 17200704 DOI: 10.1172/JCI30085]
27. Kawahito Y, Sano H, Mukai S, Asai K, Kimura S, Yamamura Y, Kato H, Chrousos GP, Wilder RL, Kondo M. Corticotropin releasing hormone in colonic mucosa in patients with ulcerative colitis. Gut 1995; 37: 544-551. [PMID: 7489943 DOI: 10.1136/gut.37.4.544]
28. Saruta M, Takahashi K, Suzuki T, Torii A, Kawakami M, Sasano H. Urocortin 1 in colonic mucosa in patients with ulcerative colitis. J Clin Endocrinol Metab 2004; 89: 5352-5361. [PMID: 15531481 DOI: 10.1210/jc.2004-0195]
29. Kohno M, Kawahito Y, Tsubouchi Y, Hashiramoto A, Yamada R, Inoue KI, Kusaka Y, Kubo T, Elenkov IJ, Chrousos GP, Kondo M, Sano H. Urocortin expression in synovium of patients with rheumatoid arthritis and osteoarthritis: relation to inflammatory activity. J Clin Endocrinol Metab 2001; 86: 4344-4352. [PMID: 11549672 DOI: 10.1210/jc.86.9.4344]
30. Moss AC, Anton P, Savidge T, Newman P, Cheifetz AS, Gay J, Paraschos S, Winter MW, Moyer MP, Karalis K, Kokkotou E, Pothoulakis C. Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2alpha. Gut 2007; 56: 1210-1217. [PMID: 17412781 DOI: 10.1136/gut.2006.110668]
31. Buckinx R, Adriaensen D, Nassauw LV, Timmermans JP. Corticotrophin-releasing factor, related peptides, and receptors in the normal and inflamed gastrointestinal tract. Front Neurosci 2011; 5: 54. [PMID: 21541251]
32. Paschos KA, Kolios G, Chatzaki E. The corticotropin-releasing factor system in inflammatory bowel disease: prospects for new therapeutic approaches. Drug Discov Today 2009; 14: 713-720. [PMID: 19379831 DOI: 10.1016/j.drudis.2009.04.002]
33. Chatzaki E, Minas V, Zoumakis E, Makrigiannakis A. CRF receptor antagonists: utility in research and clinical practice. Curr Med Chem 2006; 13: 2751-2760. [PMID: 17073626 DOI: 10.2174/092986706778521977]
34. Gonzalez-Rey E, Fernandez-Martin A, Chorny A, Delgado M. Therapeutic effect of urocortin and adrenomedullin in a murine model of Crohn's disease. Gut 2006; 55: 824-832. [PMID: 16401687 DOI: 10.1136/gut.2005.084525]
35. Yuan PQ, Wu SV, Elliott J, Anton PA, Chatzaki E, Million M, Taché Y. Expression of corticotropin releasing factor receptor type 1 (CRF1) in the human gastrointestinal tract and upregulation in the colonic mucosa in patients with ulcerative colitis. Peptides 2012; 38: 62-69. [PMID: 22948128 DOI: 10.1016/j.peptides.2012.07.028]
36. Chang J, Adams MR, Clifton MS, Liao M, Brooks JH, Hasdemir B, Bhargava A. Urocortin 1 modulates immunosignaling in a rat model of colitis via corticotropin-releasing factor receptor 2. Am J Physiol Gastrointest Liver Physiol 2011; 300: G884-G894. [PMID: 21330446 DOI: 10.1152/ajpgi.00319.2010]
37. Charalampopoulos I, Androulidaki A, Minas V, Chatzaki E, Tsatsanis C, Notas G, Xidakis C, Kolios G, Kouroumalis E, Margioris AN, Gravanis A. Neuropeptide urocortin and its receptors are expressed in rat Kupffer cells. Neuroendocrinology 2006; 84: 49-57. [PMID: 17090973 DOI: 10.1159/000096827]
38. Chatzaki E, Crowe PD, Wang L, Million M, Taché Y, Grigoriadis DE. CRF receptor type 1 and 2 expression and anatomical distribution in the rat colon. J Neurochem 2004; 90: 309-316. [PMID: 15228587 DOI: 10.1111/j.1471-4159.2004.02490.x]
39. Chatzaki E, Murphy BJ, Wang L, Million M, Ohning GV, Crowe PD, Petroski R, Taché Y, Grigoriadis DE. Differential profile of CRF receptor distribution in the rat stomach and duodenum assessed by newly developed CRF receptor antibodies. J Neurochem 2004; 88: 1-11. [PMID: 14675144 DOI: 10.1046/j.1471-4159.2003.02078.x]
40. Muramatsu Y, Fukushima K, Iino K, Totsune K, Takahashi K, Suzuki T, Hirasawa G, Takeyama J, Ito M, Nose M, Tashiro A, Hongo M, Oki Y, Nagura H, Sasano H. Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa. Peptides 2000; 21: 1799-1809. [PMID: 11150640 DOI: 10.1016/S0196-9781(00)00335-1]
41. Wallon C, Yang PC, Keita AV, Ericson AC, McKay DM, Sherman PM, Perdue MH, Söderholm JD. Corticotropinreleasing hormone (CRH) regulates macromolecular permeability via mast cells in normal human colonic biopsies in vitro. Gut 2008; 57: 50-58. [PMID: 17525093 DOI: 10.1136/ gut.2006.117549]
42. Liu S, Gao N, Hu HZ, Wang X, Wang GD, Fang X, Gao X, Xia Y, Wood JD. Distribution and chemical coding of corticotropin-releasing factor-immunoreactive neurons in the guinea pig enteric nervous system. J Comp Neurol 2006; 494: 63-74. [PMID: 16304680]
43. Gourcerol G, Wu SV, Yuan PQ, Pham H, Miampamba M, Larauche M, Sanders P, Amano T, Mulak A, Im E, Pothoulakis C, Rivier J, Taché Y, Million M. Activation of corticotropinreleasing factor receptor 2 mediates the colonic motor coping response to acute stress in rodents. Gastroenterology 2011; 140: 1586-1596. e6. [PMID: 21277852 DOI: 10.1002/cne.20781]
44. Saruta M, Takahashi K, Suzuki T, Fukuda T, Torii A, Sasano H. Urocortin 3/stresscopin in human colon: possible modulators of gastrointestinal function during stressful conditions. Peptides 2005; 26: 1196-1206. [PMID: 15949638 DOI: 10.1016/ j.peptides.2005.01.014]
45. Kokkotou E, Torres D, Moss AC, O'Brien M, Grigoriadis DE, Karalis K, Pothoulakis C. Corticotropin-releasing hormone receptor 2-deficient mice have reduced intestinal inflammatory responses. J Immunol 2006; 177: 3355-3361. [PMID: 16920976]
46. Moyer MP, Manzano LA, Merriman RL, Stauffer JS, Tanzer LR. NCM460, a normal human colon mucosal epithelial cell line. In Vitro Cell Dev Biol Anim 1996; 32: 315-317. [PMID: 8842743 DOI: 10.1007/BF02722955]
47. Wallon C, Persborn M, Jönsson M, Wang A, Phan V, Lampinen M, Vicario M, Santos J, Sherman PM, Carlson M, Ericson AC, McKay DM, Söderholm JD. Eosinophils express muscarinic receptors and corticotropin-releasing factor to disrupt the mucosal barrier in ulcerative colitis. Gastroenterology 2011; 140: 1597-1607. [PMID: 21277851 DOI: 10.1053/ j.gastro.2011.01.042]
48. Ng ML, Healy DL, Rajna A, Fullerton M, O'Grady C, Funder JW. Presence of pro-opiomelanocortin peptides and corticotropin-releasing factor in human placenta. Malays J Pathol 1996; 18: 59-63. [PMID: 10879226]
49. Chang J, Hoy JJ, Idumalla PS, Clifton MS, Pecoraro NC, Bhargava A. Urocortin 2 expression in the rat gastrointestinal tract under basal conditions and in chemical colitis. Peptides 2007; 28: 1453-1460. [PMID: 17586086 DOI: 10.1016/ j.peptides.2007.05.008]
50. Wlk M, Wang CC, Venihaki M, Liu J, Zhao D, Anton PM, Mykoniatis A, Pan A, Zacks J, Karalis K, Pothoulakis C. Corticotropin-releasing hormone antagonists possess anti-inflammatory effects in the mouse ileum. Gastroenterology 2002; 123: 505-515. [PMID: 12145804 DOI: 10.1053/gast.2002.34783]
51. Uzuki M, Sasano H, Muramatsu Y, Totsune K, Takahashi K, Oki Y, Iino K, Sawai T. Urocortin in the synovial tissue of patients with rheumatoid arthritis. Clin Sci (Lond) 2001; 100: 577-589. [PMID: 11352772 DOI: 10.1042/CS20000242]
52. Chatzaki E, Charalampopoulos I, Leontidis C, Mouzas IA, Tzardi M, Tsatsanis C, Margioris AN, Gravanis A. Urocortin in human gastric mucosa: relationship to inflammatory activity. J Clin Endocrinol Metab 2003; 88: 478-483. [PMID: 12519893 DOI: 10.1210/jc.2002-020853]
53. Paschos KA, Charsou C, Constantinidis TC, Anagnostoulis S, Lambropoulou M, Papachristou F, Simopoulos K, Chatzaki E. Corticotropin-releasing hormone receptors mediate opposing effects in cholestasis-induced liver cell apoptosis. Endocrinology 2010; 151: 1704-1712. [PMID: 20189999 DOI: 10.1210/en.2009-1208]
54. Dermitzaki E, Tsatsanis C, Minas V, Chatzaki E, Charalampopoulos I, Venihaki M, Androulidaki A, Lambropoulou M, Spiess J, Michalodimitrakis E, Gravanis A, Margioris AN. Corticotropin-releasing factor (CRF) and the urocortins differentially regulate catecholamine secretion in human and rat adrenals, in a CRF receptor type-specific manner. Endocrinology 2007; 148: 1524-1538. [PMID: 17194738 DOI: 10.1210/ en.2006-0967]
55. Liu S, Ren W, Qu MH, Bishop GA, Wang GD, Wang XY, Xia Y, Wood JD. Differential actions of urocortins on neurons of the myenteric division of the enteric nervous system in guinea pig distal colon. Br J Pharmacol 2010; 159: 222-236. [PMID: 20002096 DOI: 10.1111/j.1476-5381.2009.00516.x]